Aim: To determine the efficacy of positron emission tomography-computed tomography using F-18 fluoro-deoxy-glucose (F-18 FDG PET-CT) in diagnosing the recurrence of renal cell carcinoma (RCC) in patients treated earlier with partial or radical nephrectomy.
Methods: We assessed 63 patients with suspected recurrent RCC after nephrectomy. PET-CT findings were interpreted as positive if the focal area of FDG uptake in the abdomen or outside the abdomen was more than the surrounding background tissue. The final diagnosis of the recurrence of RCC was based on histological examination and/or clinical follow-up and conventional imaging modalities.
Results: A total of 103 PET-CT studies were done in these 63 patients, of which 63 studies were true positive, 30 studies were true negative, seven studies were false negative and remaining three studies were false positive. In 63 true-positive scans, PET-CT showed 109 lesions. Of these, 28 lesions were in the lungs, 21 lesions were at a locoregional site, 21 were in the bones, 12 in the retroperitoneal lymph nodes and 27 at other sites. The sensitivity, specificity and accuracy of PET-CT were 90, 91 and 90%, respectively.
Conclusion: Our results seem to confirm the useful role of PET-CT in the evaluation of post-surgical recurrence in patients who had undergone radical surgery for RCC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MNM.0b013e32833d6882 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Utility of F-FDG PET/CT and Cardiac MRI in Early Cardiac Sarcoidosis.
Indian Heart J
March 2025
Department of Cardiology, AIG Hospitals, Hyderabad, India. Electronic address:
Background And Aims: Although F-FDG-PET/CT and CMR are commonly used to diagnose cardiac sarcoidosis(CS), their clinical utility in early- vs. late-stage disease is unclear. The objective of this study was to compare the diagnostic utility of 18-fluorodeoxyglucose positron emission tomography/computed tomography(F-FDG-PET/CT) and cardiac magnetic resonance imaging(CMR) in patients with early- and late-stage CS.
View Article and Find Full Text PDFMetabolic tumor parameters on F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma.
Ann Nucl Med
March 2025
Department of Nuclear Medicine, West China Hospital of Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, People's Republic of China.
Objective: This study aimed to comprehensively evaluate the performance of fluorine-18 fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) and investigate the association between metabolic parameters, programmed cell death ligand 1 (PD-L1) expression, and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma (FHRCC).
Methods: Twenty-nine patients with FHRCC were prospectively enrolled from May 2020 to February 2023 for F-FDG PET/CT. The maximum standardized uptake value (SUVmax), peak standardized uptake value (SUVpeak), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) of primary/recurrent tumors were analyzed.
Imaging in sarcoid disease.
Best Pract Res Clin Rheumatol
March 2025
Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA. Electronic address:
Sarcoidosis is a complex multisystem inflammatory disease characterized by noncaseating granulomas and variable clinical manifestations, most commonly affecting the lungs, skin, heart, and nervous system. Imaging is central in its diagnosis, staging, and management, providing essential insights into organ involvement and disease activity. Pulmonary manifestations remain the hallmark, with modalities such as high-resolution chest computed tomography (CT) and chest radiography offering critical diagnostic clues.
View Article and Find Full Text PDFLarge-vessel vasculitis in a patient presenting with new onset erectile pain, myalgias and lower limb claudication.
BMJ Case Rep
March 2025
Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia.
Early manifestations of large-vessel vasculitis are often non-specific, which can result in missed or delayed diagnosis. A case of Takayasu arteritis with femoral artery predominance diagnosed using fluorodeoxyglucose-positron emission tomography/CT (FDG-PET/CT) imaging in a patient with fevers, myalgia, lower limb claudication and erectile pain is presented in this report. This case report describes an unusual genitourinary manifestation of vasculitis and highlights the utility of FDG-PET/CT in the diagnostic work-up of patients with fever of unknown origin.
View Article and Find Full Text PDFSuperiority of Ga-DOTA-FAPI-04 PET/CT to F-FDG PET/CT in the evaluation of different cancers with bone metastases.
Bone
March 2025
Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing 100142, China. Electronic address:
Background: Ga-DOTA-FAPI-04 is a new positron imaging agent, and its application in bone metastasis has been limited. The purpose of this retrospective study was to compare the diagnostic ability of Ga-DOTA-FAPI-04 PET/CT and F-FDG PET/CT to detect bone metastases in patients with different types of cancer.
Methods: A total of 293 patients with pathologically confirmed primary malignancies were examined with Ga-DOTA-FAPI-04 PET/CT and F-FDG PET/CT within one week.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!